A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
ID: 75N91024R00018Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH NCIBethesda, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (AN11)

Original Source

https://sam.gov/opp/e57dec8656b9444fa2fd0e6ca480c3f6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking capability statements from organizations for a contract focused on the collection and evaluation of human tissues, cells, and biofluids from donors with epidemiologic profiles. This initiative aims to support molecular epidemiology studies related to various cancers, including lung, breast, liver, and pancreatic cancer, and involves tasks such as participant recruitment, biological specimen collection, and data processing while ensuring compliance with ethical regulations. The contract, anticipated to last five years, builds on efforts initiated in 1996 and emphasizes the importance of delivering viable tissues promptly and maintaining data confidentiality. Interested organizations, excluding the current provider, must submit their qualifications by February 18, 2025, and can contact Whitney D. Monkama at whitney.monkam@nih.gov or +1 240 276 5446 for further information.

    Point(s) of Contact
    MONKAM, WHITNEY D
    +1 240 276 5446
    whitney.monkam@nih.gov
    Files
    Title
    Posted
    Sources_Sought-_Final_1.docx
    Sources Sought- Final.pdf
    The National Cancer Institute (NCI) is seeking capability statements from organizations regarding a contract for the collection and evaluation of human tissues, cells, and bio-fluids from donors with an epidemiologic profile. This initiative, managed by the Laboratory of Human Carcinogenesis, is intended to support molecular epidemiology studies focused on various cancers, including lung, breast, liver, and pancreatic cancer. The contractor will be tasked with recruiting participants, collecting biological specimens, processing epidemiological data, and ensuring compliance with ethical regulations. The contract aims to continue and enhance previous efforts that started in 1996, shifting from tissue collection for experimental development to comprehensive case-control studies. Eligible organizations should respond by outlining their ability to meet the project's requirements, which include delivering viable tissues within three hours and maintaining data confidentiality. The anticipated contract period is five years, with considerations for small business set-asides. The notice encourages potential applicants, excluding the current provider, to demonstrate their qualifications and capabilities by submitting statements by February 18, 2025.
    SOW_DRAFT 01.15.25.pdf
    The draft Statement of Work outlines the objectives and tasks for a contractor supporting the Laboratory of Human Carcinogenesis (LHC) in researching the molecular epidemiology of human cancer. Key responsibilities include recruiting cancer cases and population-based controls, collecting and processing biological specimens, and maintaining ethical and legal approvals. The contractor is expected to accrue targeted cancer case numbers annually, covering various types including lung, liver, and pancreatic cancers, while also gathering demographic and medical data through structured questionnaires. Biological samples must be handled and stored per regulatory standards, with regular reporting and data management requirements. The document emphasizes compliance with the Privacy Act and health regulations, as well as ensuring accessibility under Section 508 standards. Transition plans for phase-in and phase-out of contract activities, alongside extensive training requirements for personnel interacting with patients, are also detailed. Overall, this work underlines a significant commitment to advancing cancer research through meticulous data collection and specimen management.
    Lifecycle
    Title
    Type
    A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
    Currently viewing
    Sources Sought
    Similar Opportunities
    GeminiBio GemCell TM Plus Xeno free Reagents.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a fixed-price contract for the supply of GeminiBio GemCell TM Plus Xeno free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. The procurement aims to secure a reliable source of reagents critical for manufacturing human cell and tissue-based products used in clinical trials, as the Center has validated GeminiBio's products for compatibility with its processes. This acquisition is vital to prevent treatment delays for patients involved in clinical trials, as switching vendors would necessitate costly and time-consuming requalification. Interested parties capable of providing similar products must submit a capability statement by January 26, 2025, to Emeka Onyejekwe at emeka.onyejekwe@nih.gov.
    CIVICs Data Management and Coordinating Center (DMCC)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide services for the renewal of the CIVICs Data Management and Coordinating Center (DMCC). The DMCC will support the CIVICs program by managing data, conducting analyses, and facilitating communication and coordination among various stakeholders, with a focus on advancing influenza vaccine research and development. This initiative is critical for enhancing the immunogenicity and durability of seasonal influenza vaccines and involves the operation of a scalable data management system, maintenance of public and private portals, and comprehensive program coordination. Interested parties must submit their tailored Capability Statements by 3:00 PM (Eastern Time) on January 23, 2025, to Maribel Miranda at maribel.miranda@nih.gov, with the anticipated contract award date around July 2026.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Chemistry, Manufacturing, and Controls (CMC) services to support the development of drug products. The objective of this procurement is to ensure the delivery of high-quality formulated drug products for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic development. This opportunity encompasses a wide range of services, including formulation development, manufacturing under current Good Manufacturing Practices (cGMP), and necessary testing to meet regulatory standards. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can contact Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    A--Data Coordinating Center (DCC) for the Best Pharmaceuticals for Children Act (B
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and its National Institute of Child Health and Human Development (NICHD), is seeking qualified small businesses to support the Data Coordinating Center (DCC) for the Best Pharmaceuticals for Children Act (BPCA). The primary objective of this procurement is to provide comprehensive data management, analysis, and regulatory reporting services for pediatric clinical trials, ensuring compliance with FDA regulations and facilitating data submission to the FDA and the NICHD Data Repository. This initiative is crucial for enhancing pediatric health outcomes by addressing therapeutic gaps and conducting necessary clinical studies, as mandated by the reauthorized BPCA. Interested parties must submit their capability statements by January 28, 2025, and can contact Deborah Brock at Deborah.Brock@nih.gov for further information.
    Hardy Diagnostic Reagents and Supplies
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract to Hardy Diagnostics for the procurement of culture media and organism supplies necessary for cGMP Sterility Testing Services. The primary objective is to ensure compliance with FDA regulations by utilizing cGMP quality materials that have been rigorously validated, as these supplies are critical for the isolation and identification of pathogens affecting critically ill patients. The contract will cover a base period of twelve months with an option for an additional three months, and interested vendors capable of providing similar products are encouraged to submit capability statements by the specified deadline. For further inquiries, potential respondents may contact Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov.
    SOURCES SOUGHT: Neurodegenerative Disease Scientific Data Analysis and Consulting Services
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small business sources for scientific data analysis and consulting services related to neurodegenerative diseases, particularly Alzheimer’s disease and related dementias. The objective of this procurement is to obtain advanced analytics support to integrate and analyze complex datasets, including imaging, genomic, and clinical data, to identify disease mechanisms and therapeutic targets. This initiative is crucial for enhancing research capabilities and ensuring data accessibility and interoperability within the scientific community. Interested parties must submit their capability statements by January 24, 2025, to Hashim Dasti at hashim.dasti@nih.gov, with no costs incurred by the government for responses.
    Clinical Studies of Infectious Agents, Vaccines and Antivirals in Adult and Pediatric Human Subjects
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), is seeking small business contractors to conduct clinical studies focused on infectious agents, vaccines, and antivirals for both adult and pediatric populations. The primary objectives include evaluating the safety, immunogenicity, and efficacy of vaccines against various viruses, including emerging threats like Zika, with a project duration anticipated from August 2026 to August 2033 under a cost-reimbursement IDIQ contract structure. This initiative builds on decades of NIH-led research and aims to advance medical research through strategic partnerships with capable small businesses. Interested parties should submit their capability statements, including prior experience and qualifications, to the primary contact, Uju Obii-Obioha, at uju.obii-obioha@nih.gov, by the specified deadlines.
    Long Read Sequencing Kits
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for the procurement of Long Read Sequencing Kits, specifically Oxford Nanopore brand or equivalent items, to support research on neurodegenerative diseases. The acquisition aims to supply the Center for Alzheimer’s Disease and Related Dementias with kits that will facilitate the identification of causative genes linked to Alzheimer's Disease and related disorders, utilizing long-read sequencing technology. This procurement is critical for advancing research in understanding and treating neurodegenerative diseases, with an anticipated delivery of the first order by September 30, 2025, and options for additional orders in subsequent years. Interested vendors must submit their quotations by 12:00 p.m. EST on January 24, 2025, to Andrea Clay at amcgee@nida.nih.gov, referencing Solicitation Number 75N95025Q00095.
    STRATEGIC CONSULTING AND PLANNING SERVICES
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to engage Colbert Consulting, LLC for strategic consulting and planning services to support the National Institute of Nursing Research (NINR). The contractor will assist in the development and implementation of a strategic plan that addresses significant health challenges, including health equity and community health, through the planning of scientific meetings and the creation of relevant scientific materials. This sole-source contract, valued at $148,800, is set to run from January 20, 2025, to January 19, 2026, and interested parties may submit capability statements to Ms. Van Holley at holleyv@od.nih.gov by January 20, 2025, at 10 AM EST.